NDC 60687-637 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC60687-637

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
American Health Packaging
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205601
Marketed since
March 14, 2022
Listing expires
December 31, 2026
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
60687-637-6550 BLISTER PACK in 1 CARTON (60687-637-65) / 1 TABLET in 1 BLISTER PACK (60687-637-11)Mar 14, 2022

Other Buprenorphine and Naloxone products